Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation. Issue 2 (20th December 2021)

• Record Type: Journal Article
• Authors: Gao, Yong; Liu, Jinhui; Cai, Baobao; Chen, Qun; Wang, Guangfu; Lu, Zipeng; Jiang, Kuirong; Miao, Yi
• Is Part Of: Bioengineered. Volume 12:Issue 2(2021)
• Page Start: 10553
• Page End: 10567
• Publication Date: 2021-12-20
• Subjects: Pancreatic cancer -- prognostic signature -- lncRNA -- tumorenvironment -- epithelial–mesenchymal transition; Biomedical engineering -- Periodicals; Biotechnology -- Periodicals; Microbiology -- Periodicals; 660.6
• DOI: 10.1080/21655979.2021.2000197
• Languages: English
• ISSNs: 2165-5987

Abstract

ABSTRACT: Long non-coding RNAs (LncRNAs) have crucial function in epithelial–mesenchymal transition (EMT) in pancreatic cancer. It is necessary to comprehensively analyze the potential role of EMT-related lncRNA in pancreatic cancer. In the present study, genomic data of pancreatic cancer from the TCGA database were downloaded and we found 368 EMT-related lncRNAs. According to the expression characteristics of prognostic-related lncRNAs, all samples could be divided into two clusters with different clinical outcomes and different tumor microenvironments. Moreover, an eleven EMT-related lncRNAs signature was established and verified. Patients with pancreatic cancer in the high-risk group had a shorter overall survival than those in the low-risk group and the signature could act as an independent prognostic factor. Further analysis suggested that the EMT-related lncRNAs might affect the prognosis of patients through immune mechanisms. All findings indicated that the signature and eleven lncRNAs might serve as potential prognostic biomarkers and therapeutic targets in the treatment of pancreatic cancer.